中文(繁體)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

PrOtein and WEight Loss in teenageRs

只有註冊用戶可以翻譯文章
登陸註冊
鏈接已保存到剪貼板
狀態已完成
贊助商
Pennington Biomedical Research Center

關鍵詞

抽象

The aim of the proposed study is to provide important data on weight loss efficacy in overweight and obese adolescents on an isocaloric higher protein diet vs a lower protein diet utilizing the U.S. Department of Agriculture (USDA) MyPlate nutrition guide. The investigators hypothesize that the higher protein diet will result in greater weight loss due to increased satiety and better dietary adherence.

描述

Aim 1 is to test the efficacy of a personalized higher protein weight loss intervention compared to a lower protein intervention which use the USDA MyPlate nutrition guide.

It is hypothesized that participants randomly assigned to the higher protein dietary treatment will lose more weight based on BMI-Z score over 12 weeks compared to participants in the lower dietary protein treatment.

Aim 2 is to test if changes in subjective ratings of appetite differ by dietary treatment (i.e. protein intake).

It is hypothesized that participants in the higher protein intervention will report a decrease in hunger and an increase in fullness compared to participants in the lower protein intervention.

Aim 3 is to test if change in the hexosamine biosynthetic pathway (HBP) measured at the rate limiting step of glutamine fructose-6-phosphate amidotransferase (GFAT) and glycosylation measured as O-linked N-acetylglucosamine (GlcNAc) transferase (OGT) differ by dietary treatment.

It is hypothesized that participants randomly assigned to the higher protein dietary treatment will have decreased change from baseline levels of GFAT and glycosylation (OGT) due to decreased carbohydrate intake compared to the lower protein treatment.

Exploratory Aims: As exploratory aims, the investigators will test if the higher protein or lower protein dietary treatments differentially alter glucose, insulin, cholesterol, and triglycerides (markers of the metabolic syndrome).

日期

最後驗證: 12/31/2015
首次提交: 03/02/2014
提交的預估入學人數: 03/04/2014
首次發布: 03/05/2014
上次提交的更新: 01/06/2016
最近更新發布: 01/10/2016
實際學習開始日期: 02/28/2014
預計主要完成日期: 06/30/2015
預計完成日期: 06/30/2015

狀況或疾病

Pediatric Obesity

干預/治療

Behavioral: Energy Restriction

Behavioral: Higher protein and energy restriction

Behavioral: Lower protein and energy restriction

-

手臂組

干預/治療
Experimental: Higher protein and energy restriction
Participants in this arm will consume 30% of energy as protein with 25% energy restriction.
Behavioral: Higher protein and energy restriction
The higher protein group will be instructed to consume 30% of energy as protein, with 25% and 45% of energy from fat and carbohydrate, respectively.
Experimental: Lower protein and energy restriction
Participants in this arm will consume 15% of energy as protein with 25% energy restriction.
Behavioral: Lower protein and energy restriction
The lower protein group will be instructed to consume 15% of energy as protein, with 25% and 60% of energy from fat and carbohydrate, respectively.

資格標準

有資格學習的年齡 12 Years 至 12 Years
有資格學習的性別All
接受健康志願者
標準

Inclusion Criteria:

- Be male or female

- Be between the ages of 12 and 17, inclusive

- Be at or above the 85th BMI percentile (a number calculated from the participants height, weight, sex, and date of birth)

- Be willing to fast for 12 hours prior to clinic study visits 2 and 4

- Be willing to participate in the research study

Exclusion Criteria:

- Health Conditions:

- Has HIV or AIDS

- Has uncontrolled CVD or arrhythmia

- Has Type I or Type II diabetes.

- Is unable or unwilling to complete the study procedures

- Participant may not qualify for this study based on other exclusion criteria not listed. The study coordinator will go over this information in detail.

Medications:

- Diuretics

- Beta-blocker

- Weight loss medications, diet pills

- Anti-inflammatory drugs (corticosteroid/anabolic steroid/NSAID)

- Antipsychotic medications

- Other medications that may affect fluid balance or weight

Lifestyle:

• Plans to move out of the study area within the next 4 months, or plan to be out of the study area for more than 3 weeks during the course of the study.

結果

主要結果指標

1. BMI Z-Score [up to Week 12]

次要成果指標

1. Subjective Ratings of Appetite [Baseline and Week 12]

2. Hexosamine Biosynthetic Pathway [Baseline and Week 12]

glutamine fructose-6-phosphate amidotransferase (GFAT) and glycosylation measured as O-linked N-acetylglucosamine (GlcNAc) transferase (OGT) measurement

其他成果措施

1. Glucose [Baseline and Week 12]

2. Insulin [Baseline and Week 12]

3. Cholesterol [Baseline and Week 12]

4. Triglycerides [Baseline and Week 12]

5. Blood Pressure [Baseline and Week 12]

加入我們的臉書專頁

科學支持的最完整的草藥數據庫

  • 支持55種語言
  • 科學支持的草藥療法
  • 通過圖像識別草藥
  • 交互式GPS地圖-在位置標記草藥(即將推出)
  • 閱讀與您的搜索相關的科學出版物
  • 通過藥效搜索藥草
  • 組織您的興趣並及時了解新聞研究,臨床試驗和專利

輸入症狀或疾病,並閱讀可能有用的草藥,輸入草藥並查看其所針對的疾病和症狀。
*所有信息均基於已發表的科學研究

Google Play badgeApp Store badge